Enhanced analgesic activity by cyclodextrins – a systematic review and meta-analysis

Bibliography

• Azevedo LF, Costa-Pereira A, Mendonça L, et al. Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal. J Pain 2012;13:773-83
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Ailinani H, Koyyalagunta D, et al. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician 2011;14:91-121
   PubMed Web of Science ®Google Scholar
• Harker J, Reid KJ, Bekkering GE, et al. Epidemiology of chronic pain in denmark and sweden. Pain Res Treat 2012;2012:371248
   PubMedGoogle Scholar
• Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain 2012;13:715-24
   PubMed Web of Science ®Google Scholar
• Dionne RA. Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:134-42
   PubMed Web of Science ®Google Scholar
• Becker DE. Pain management: Part 1: Managing acute and postoperative dental pain. Anesth Prog 2010;57:67-78
   PubMedGoogle Scholar
• Clauw DJ, Arnold LM, McCarberg BH. The science of fibromyalgia. Mayo Clin Proc 2011;86:907-11
   PubMed Web of Science ®Google Scholar
• Xu B, Descalzi G, Ye H-R, et al. Translational investigation and treatment of neuropathic pain. Mol Pain 2012;8:15
   PubMed Web of Science ®Google Scholar
• Abdel-Tawab M, Zettl H, Schubert-Zsilavecz M. Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicity. Curr Med Chem 2009;16:2042-63
   PubMed Web of Science ®Google Scholar
• Laza-Knoerr AL, Gref R, Couvreur P. Cyclodextrins for drug delivery. J Drug Target 2010;18:645-56
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017-25
   PubMed Web of Science ®Google Scholar
• Scarpignato C. Piroxicam-β-cyclodextrin: a GI safer piroxicam. Curr Med Chem 2013;20:2415-37
   PubMed Web of Science ®Google Scholar
• Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem 2004;39:1033-46
   Web of Science ®Google Scholar
• Quintans J de SS, Menezes PP, Santos MRV, et al. Improvement of p-cymene antinociceptive and anti-inflammatory effects by inclusion in β-cyclodextrin. Phytomedicine 2013;20:436-40
   PubMed Web of Science ®Google Scholar
• Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: a review. Acta Pharm Zagreb Croat 2013;63:335-58
   PubMed Web of Science ®Google Scholar
• Pinho E, Grootveld M, Soares G, Henriques M. Cyclodextrins as encapsulation agents for plant bioactive compounds. Carbohydr Polym 2014;101:121-35
   PubMed Web of Science ®Google Scholar
• Stella VJ, He Q. Cyclodextrins. Toxicol Pathol 2008;36:30-42
   PubMed Web of Science ®Google Scholar
• Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;6:E329-57
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9; W64
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, G?tzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928
   PubMed Web of Science ®Google Scholar
• Gan TJ, Daniels SE, Singla N, et al. A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesth Analg 2012;115:1212-20
   PubMed Web of Science ®Google Scholar
• Christensen K, Daniels S, Bandy D, et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesth Prog 2011;58:73-81
   PubMedGoogle Scholar
• Keleş GT, Topçu I, Ekici Z, Yentür A. Evaluation of piroxicam-beta-cyclodextrin as a preemptive analgesic in functional endoscopic sinus surgery. Braz J Med Biol Res 2010;43:806-11
   PubMed Web of Science ®Google Scholar
• Chang S-T, Chen L-C, Chang C-C, et al. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain. J Clin Pharm Ther 2008;33:495-506
   PubMed Web of Science ®Google Scholar
• Shin-Tsu Chang L-CC. Efficacy and safety of piroxicam beta-cyclodextrin sachets for treating chronic low back pain: a randomized, parallel, active-controlled trial. J Med Sci 2008;28
   PubMedGoogle Scholar
• Pijak MR, Turcani P, Turcaniova Z, et al. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain. Bratisl Lekárske Listy 2002;103:467-72
   PubMedGoogle Scholar
• Fioravanti A, Storri L, Di Martino S, et al. A randomized, double-blind, multicenter trial of nimesulide-beta-cyclodextrin versus naproxen in patients with osteoarthritis. Clin Ther 2002;24:504-19
   PubMed Web of Science ®Google Scholar
• Siqueira-Lima PS, Araújo AAS, Lucchese AM, et al. β-cyclodextrin complex containing lippia grata leaf essential oil reduces orofacial nociception in mice - evidence of possible involvement of descending inhibitory pain modulation pathway. Basic Clin Pharmacol Toxicol 2014;114:188-96
   PubMed Web of Science ®Google Scholar
• Quintans-Júnior LJ, Barreto RSS, Menezes PP, et al. β-Cyclodextrin-complexed (-)-linalool produces antinociceptive effect superior to that of (-)-linalool in experimental pain protocols. Basic Clin Pharmacol Toxicol 2013;113:167-72
   PubMed Web of Science ®Google Scholar
• El-Feky G, El-Banna S, Khalil S. Preparation, in vitro and in vivo evaluation of oral indomethacin-HP-B-Cyclodextrin loaded chitosan nanoparticules. Int J Pharm Pharm Sci 2013;5:638-45
   Google Scholar
• Dolita K. Formulation and characterization of inclusion complex of acetyl salicylic acid (aspirin) and b-cyclodextrin vy solvent evaporation & its comparatives study to aspirin alone. Int J Pharm Sci Res 2012;3:2831-6
   Google Scholar
• Singh I, Kumar P, Pahuja S, et al. Development and pharmacological evaluation of cyclodextrin complexes of etoricoxib. Acta Pol Pharm 2011;68:279-84
   PubMed Web of Science ®Google Scholar
• Janovský M, Dolezal T, Procháizková M, et al. Influence on analgesic activity and serum levels after meloxicam complexation with beta-cyclodextrin in mice and rats. Arzneimittelforschung 2010;60:320-3
   PubMed Web of Science ®Google Scholar
• Sinha VR, Amita Goel H. In vivo bioavailability and therapeutic assessment of host-guest inclusion phenomena for the hydrophobic molecule etodolac: pharmacodynamic and pharmacokinetic evaluation. Sci Pharm 2010;78:103-15
   PubMedGoogle Scholar
• Cappello B, di Maio C, Iervolino M, et al. Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies. Drug Dev Ind Pharm 2009;35:877-86
   PubMed Web of Science ®Google Scholar
• Lu W-L, Zhang Q, Zheng L, et al. Antipyretic, analgesic and anti-inflammatory activities of ketoprofen beta-cyclodextrin inclusion complexes in animals. Biol Pharm Bull 2004;27:1515-20
   PubMed Web of Science ®Google Scholar
• Astruc-Diaz F, McDaniel SW, Xu JJ, et al. In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7. J Pharm Sci 2013;102:352-64
   PubMed Web of Science ®Google Scholar
• Svensson E, Persson J, Fitzsimmons B, Yaksh TL. Intrathecal neurosteroids and a neurosteroid antagonist: effects on inflammation-evoked thermal hyperalgesia and tactile allodynia. Neurosci Lett 2013;548:27-32
   PubMed Web of Science ®Google Scholar
• Franco de Lima RA, de Jesus MB, Saia Cereda CM, et al. Improvement of tetracaine antinociceptive effect by inclusion in cyclodextrins. J Drug Target 2012;20:85-96
   PubMed Web of Science ®Google Scholar
• Volobuef C, Moraes CM, Nunes LAS, et al. Sufentanil-2-hydroxypropyl-β-cyclodextrin inclusion complex for pain treatment: physicochemical, cytotoxicity, and pharmacological evaluation. J Pharm Sci 2012;101:3698-707
   PubMed Web of Science ®Google Scholar
• Sammeta SM, Vaka SRK, Murthy SN. Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia. J Control Release Off 2010;142:361-7
   PubMed Web of Science ®Google Scholar
• Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 2010;26:1715-31
   PubMed Web of Science ®Google Scholar
• Marret E, Kurdi O, Zufferey P, Bonnet F. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology 2005;102:1249-60
   PubMed Web of Science ®Google Scholar
• McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994;59:9-43
   PubMed Web of Science ®Google Scholar
• Koes B, Scholten R, Mens J, Bouter L. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis 1997;56:214-23
   PubMed Web of Science ®Google Scholar
• Acerbi DD. Pharmacokinetic Profile of Piroxicam-β-Cyclodextrin. Drug Investig 1990;2:42-9
   Google Scholar
• Woodcock BG, Acerbi D, Merz PG, et al. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man. Eur J Rheumatol Inflamm 1993;12:12-28
   PubMedGoogle Scholar
• Lee CR, Balfour JA. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states. Drugs 1994;48:907-29
   PubMed Web of Science ®Google Scholar
• Davoli L, Ciotti G, Biondi M, Passeri M. Piroxicam-beta-cyclodextrin in the treatment of low-back pain: controlled study vs etodolac. Curr Ther Res 1989;46:940-7
   Web of Science ®Google Scholar
• Rainsford KD. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006;22:1161-70
   PubMed Web of Science ®Google Scholar
• Batista PA, Werner MF de P, Oliveira EC, et al. Evidence for the involvement of ionotropic glutamatergic receptors on the antinociceptive effect of (-)-linalool in mice. Neurosci Lett 2008;440:299-303
   PubMed Web of Science ®Google Scholar
• Elisabetsky E, Brum LF, Souza DO. Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine 1999;6:107-13
   PubMed Web of Science ®Google Scholar
• Venâncio AM, Marchioro M, Estavam CS, et al. Ocimum basilicum leaf essential oil and (-)-linalool reduce orofacial nociception in rodents: a behavioral and electrophysiological approach. Rev Bras Farmacogn 2011;21:1043-51
   Google Scholar
• Siani AC, Ramos MF, Menezes-de-Lima OJr, et al. Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. J Ethnopharmacol 1999;66:57-69
   PubMed Web of Science ®Google Scholar
• Bonjardim LR, Cunha ES, Guimarães AG, et al. Evaluation of the anti-inflammatory and antinociceptive properties of p-cymene in mice. Z Für Naturforschung C J Biosci 2012;67:15-21
   PubMed Web of Science ®Google Scholar
• Xie G, Chen N, Soromou LW, et al. p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Mol Basel Switz 2012;17:8159-73
   Google Scholar
• Marreto RN, Almeida EECV, Alves PB, et al. Thermal analysis and gas chromatography coupled mass spectrometry analyses of hydroxypropyl-β-cyclodextrin inclusion complex containing Lippia gracilis essential oil. Thermochim Acta 2008;475:53-8
   Web of Science ®Google Scholar
• Menezes PP, Serafini MR, Santana BV, et al. Solid-state β-cyclodextrin complexes containing geraniol. Thermochim Acta 2012;548:45-50
   Web of Science ®Google Scholar
• Ciobanu A, Mallard I, Landy D, et al. Inclusion interactions of cyclodextrins and crosslinked cyclodextrin polymers with linalool and camphor in Lavandula angustifolia essential oil. Carbohydr Polym 2012;87:1963-70
   Web of Science ®Google Scholar
• Menezes PP, Serafini MR, Quintans-Júnior LJ, et al. Inclusion complex of (−)-linalool and β-cyclodextrin. J Therm Anal Calorim 2014;115:2429-2437
   Web of Science ®Google Scholar
• Dillon CT, Hambley TW, Kennedy BJ, et al. Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinflammatory drug indomethacin. Chem Res Toxicol 2003;16:28-37
   PubMed Web of Science ®Google Scholar
• Moon H-G, Kang CS, Choi J-P, et al. Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback. Exp Mol Med 2013;45:e6
   PubMed Web of Science ®Google Scholar
• Rubin BR, Burton R, Navarra S, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial. Arthritis Rheum 2004;50:598-606
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ, Hochberg MC. COX-2-selective inhibitors in the treatment of arthritis. Cleve Clin J Med 2002;69:SI20
   PubMedGoogle Scholar
• Akbulut N, Ustüner E, Atakan C, Cölok G. Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: A randomised, double-blind, crossover study. Med Oral Patol 2014;19:e149-56
   PubMed Web of Science ®Google Scholar
• Kaur N, Singh H, Gupta AC. Randomized Controlled Trial of Etodolac versus Combination of Etodolac and Eperisone in Patients of Knee Osteoarthritis. Pain Res Treat 2013;2013:273695
   Google Scholar
• Duangjit S, Obata Y, Sano H, et al. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam. Biol Pharm Bull 2014;37:239-47
   PubMed Web of Science ®Google Scholar
• Maślanka T, Jaroszewski JJ. In vitro effects of meloxicam on the number, Foxp3 expression, production of selected cytokines, and apoptosis of bovine CD25+CD4+ and CD25-CD4+ cells. J Vet Sci 2013;14:125-34
   PubMed Web of Science ®Google Scholar
• Carbone C, Rende P, Comberiati P, et al. The safety of ketoprofen in different ages. J Pharmacol Pharmacother 2013;4:S99-S103
   Google Scholar
• Saleem MA, Bala S, Liyakat Aeajaz A. Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin. Indian J Pharm Sci 2010;72:710-18
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and beta-cyclodextrin: Mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 2004;5:63-8
   Web of Science ®Google Scholar
• Naguib M, Diaz P, Xu JJ, et al. MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models. Br J Pharmacol 2008;155:1104-16
   PubMed Web of Science ®Google Scholar
• Naguib M, Xu JJ, Diaz P, et al. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg 2012;114:1104-20
   PubMed Web of Science ®Google Scholar
• Akk G, Covey DF, Evers AS, et al. Mechanisms of neurosteroid interactions with GABAA receptors. Pharmacol Ther 2007;116:35-57
   PubMed Web of Science ®Google Scholar
• Jevtovic-Todorovic V, Covey DF, Todorovic SM. Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain? Psychoneuroendocrinology 2009;34:S178-85
   PubMedGoogle Scholar
• Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 2010;186:113-37
   PubMed Web of Science ®Google Scholar
• Giannakopoulos H, Levin LM, Chou JC, et al. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline Preliminary findings. J Am Dent Assoc 2012;143:872-80
   PubMed Web of Science ®Google Scholar
• Wilhelm W, Kreuer S. The place for short-acting opioids: special emphasis on remifentanil. Crit Care 2008;12:S5
   PubMed Web of Science ®Google Scholar
• Rajewski RA, Stella VJ. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 1996;85:1142-69
   PubMed Web of Science ®Google Scholar
• Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997;86:147-62
   PubMed Web of Science ®Google Scholar
• Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001;62:453-63
   PubMed Web of Science ®Google Scholar
• Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994;31:613-16
   PubMed Web of Science ®Google Scholar
• Gharzi M, Dolatabadi HRD, Reisi P, Javanmard SH. Effects of different doses of doxepin on passive avoidance learning in rats. Adv Biomed Res 2013;2:66
   Google Scholar